Connect
MJA
MJA

Subsidised access to TNFα inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Lloyd N Sansom
Med J Aust 2004; 181 (8): 457-458.
Published online: 18 October 2004

Lloyd N Sansom

  • Lloyd N Sansom

  • Australian Pharmaceutical Benefits Advisory Committee, School of Pharmacy, University of South Australia, Adelaide, SA 5000.

Correspondence: Lloyd.Sansom@unisa.edu.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.